AMERICAN ASSOCIATION FOR CANCER RESEARCH Bottom Line: Incidence and severity of neurological side effects from chimeric antigen receptor (CAR) T-cell therapy were higher in patients who had hypophosphatemia (low blood phosphate levels). Journal in Which the Study was Published: Cancer Immunology Research, a journal of the American Association for Cancer Research. Authors: Theodore Scott Nowicki, MD, PhD, assistant...